Soligenix
SNGX
#10288
Rank
S$14.06 M
Marketcap
S$1.39
Share price
-0.90%
Change (1 day)
-55.58%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -S$16.34 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$11.85 Million a decrease over its 2023 earnings that were of -S$9.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$16.34 Million37.88%
2024 -S$11.85 Million22.96%
2023 -S$9.64 Million-45.74%
2022 -S$17.76 Million11.88%
2021 -S$15.88 Million-32.37%
2020 -S$23.47 Million83.18%
2019 -S$12.82 Million11.57%
2018 -S$11.49 Million19.29%
2017 -S$9.63 Million33%
2016 -S$7.24 Million-19.7%
2015 -S$9.02 Million5.16%
2014 -S$8.58 Million
2010 -S$9.68 Million26.12%
2009 -S$7.68 Million75.1%
2008 -S$4.39 Million-45.38%
2007 -S$8.02 Million-22.84%
2006 -S$10.4 Million66.15%
2005 -S$6.26 Million-16.65%
2004 -S$7.51 Million13.28%
2003 -S$6.63 Million-11.88%
2002 -S$7.52 Million-59.44%
2001 -S$18.54 Million378.18%
2000 -S$3.88 Million-38.53%
1999 -S$6.31 Million-18.43%
1998 -S$7.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.06 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.02 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.53 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-S$23.02 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$52.94 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.72 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-S$3.49 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.20 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA